Arie Belldegrun - Aug 31, 2022 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ /s/ Jason Smith, Attorney-in-Fact
Stock symbol
URGN
Transactions as of
Aug 31, 2022
Transactions value $
$16,205
Form type
4
Date filed
9/2/2022, 11:40 AM
Previous filing
Jun 29, 2022
Next filing
Sep 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise $16.2K +3.24K +1.32% $5.00 249K Aug 31, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Stock Option (right to buy) Options Exercise $0 -3.24K -100% $0.00* 0 Aug 31, 2022 Ordinary Shares 3.24K $5.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.